China National Accord Medicines Corporation Ltd. (000028.SZ)
CNY 29.96
(-0.5%)
CNY 29.96
(-0.5%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 13.75 Billion CNY | 290.87% |
| 2022 | 3.51 Billion CNY | -16.74% |
| 2021 | 4.22 Billion CNY | 14.35% |
| 2020 | 3.69 Billion CNY | 14.17% |
| 2019 | 3.23 Billion CNY | 22.84% |
| 2018 | 2.63 Billion CNY | 64.86% |
| 2017 | 1.59 Billion CNY | 3.18% |
| 2016 | 1.54 Billion CNY | 20.0% |
| 2015 | 1.29 Billion CNY | -17.34% |
| 2014 | 1.56 Billion CNY | -43.27% |
| 2013 | 2.75 Billion CNY | 49.51% |
| 2012 | 1.84 Billion CNY | -5.91% |
| 2011 | 1.95 Billion CNY | 94.62% |
| 2010 | 1 Billion CNY | 0.13% |
| 2009 | 1 Billion CNY | 115.18% |
| 2008 | 466.66 Million CNY | 40.51% |
| 2007 | 332.11 Million CNY | -15.86% |
| 2006 | 394.7 Million CNY | 3847.06% |
| 2005 | 10 Million CNY | -20.0% |
| 2004 | 12.5 Million CNY | -93.5% |
| 2003 | 192.35 Million CNY | 11.73% |
| 2002 | 172.15 Million CNY | -28.36% |
| 2001 | 240.31 Million CNY | 356.61% |
| 2000 | 52.62 Million CNY | 8.98% |
| 1999 | 48.29 Million CNY | -30.58% |
| 1998 | 69.56 Million CNY | -27.03% |
| 1997 | 95.32 Million CNY | 96.95% |
| 1996 | 48.4 Million CNY | 206.34% |
| 1995 | 15.8 Million CNY | -58.17% |
| 1994 | 37.76 Million CNY | -25.34% |
| 1993 | 50.58 Million CNY | -31.92% |
| 1992 | 74.29 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 4.3 Billion CNY | -18.01% |
| 2024 Q2 | 7.15 Billion CNY | -49.88% |
| 2024 Q1 | 14.26 Billion CNY | 3.75% |
| 2023 Q1 | 5.68 Billion CNY | 61.61% |
| 2023 Q2 | 6.33 Billion CNY | 11.35% |
| 2023 Q4 | 13.75 Billion CNY | 103.26% |
| 2023 Q3 | 6.76 Billion CNY | 6.86% |
| 2023 FY | 13.75 Billion CNY | 290.87% |
| 2022 Q3 | 5.16 Billion CNY | -4.5% |
| 2022 Q1 | 5.38 Billion CNY | 27.33% |
| 2022 FY | 3.51 Billion CNY | -16.74% |
| 2022 Q4 | 3.51 Billion CNY | -31.92% |
| 2022 Q2 | 5.41 Billion CNY | 0.56% |
| 2021 Q1 | 6.05 Billion CNY | 63.77% |
| 2021 Q2 | 6.85 Billion CNY | 13.25% |
| 2021 Q3 | 5.57 Billion CNY | -18.7% |
| 2021 Q4 | 4.22 Billion CNY | -24.17% |
| 2021 FY | 4.22 Billion CNY | 14.35% |
| 2020 Q3 | 5.29 Billion CNY | -4.49% |
| 2020 FY | 3.69 Billion CNY | 14.17% |
| 2020 Q1 | 4.66 Billion CNY | 44.17% |
| 2020 Q2 | 5.54 Billion CNY | 18.78% |
| 2020 Q4 | 3.69 Billion CNY | -30.2% |
| 2019 FY | 3.23 Billion CNY | 22.84% |
| 2019 Q1 | 3 Billion CNY | 14.01% |
| 2019 Q2 | 5.03 Billion CNY | 67.61% |
| 2019 Q3 | 4.12 Billion CNY | -18.16% |
| 2019 Q4 | 3.23 Billion CNY | -21.46% |
| 2018 Q2 | 2.08 Billion CNY | 18.54% |
| 2018 Q1 | 1.76 Billion CNY | 10.22% |
| 2018 Q3 | 2.22 Billion CNY | 6.52% |
| 2018 FY | 2.63 Billion CNY | 64.86% |
| 2018 Q4 | 2.63 Billion CNY | 18.46% |
| 2017 FY | 1.59 Billion CNY | 3.18% |
| 2017 Q4 | 1.59 Billion CNY | -0.18% |
| 2017 Q3 | 1.6 Billion CNY | -2.2% |
| 2017 Q2 | 1.63 Billion CNY | 4.05% |
| 2017 Q1 | 1.57 Billion CNY | 1.58% |
| 2016 Q3 | 1.31 Billion CNY | -2.26% |
| 2016 FY | 1.54 Billion CNY | 20.0% |
| 2016 Q2 | 1.34 Billion CNY | -4.13% |
| 2016 Q1 | 1.4 Billion CNY | 9.01% |
| 2016 Q4 | 1.54 Billion CNY | 17.49% |
| 2015 Q2 | 2.04 Billion CNY | -1.07% |
| 2015 FY | 1.29 Billion CNY | -17.34% |
| 2015 Q1 | 2.06 Billion CNY | 32.25% |
| 2015 Q3 | 2 Billion CNY | -2.1% |
| 2015 Q4 | 1.29 Billion CNY | -35.46% |
| 2014 Q2 | 1.44 Billion CNY | -25.0% |
| 2014 Q4 | 1.56 Billion CNY | 2.7% |
| 2014 FY | 1.56 Billion CNY | -43.27% |
| 2014 Q1 | 1.92 Billion CNY | -29.9% |
| 2014 Q3 | 1.52 Billion CNY | 5.07% |
| 2013 Q3 | 2.39 Billion CNY | 20.8% |
| 2013 Q2 | 1.98 Billion CNY | 0.37% |
| 2013 Q1 | 1.97 Billion CNY | 7.3% |
| 2013 FY | 2.75 Billion CNY | 49.51% |
| 2013 Q4 | 2.75 Billion CNY | 14.92% |
| 2012 Q2 | 1.96 Billion CNY | -6.57% |
| 2012 Q3 | 2.08 Billion CNY | 6.21% |
| 2012 Q4 | 1.84 Billion CNY | -11.79% |
| 2012 FY | 1.84 Billion CNY | -5.91% |
| 2012 Q1 | 2.1 Billion CNY | 7.49% |
| 2011 Q4 | 1.95 Billion CNY | 21.92% |
| 2011 FY | 1.95 Billion CNY | 94.62% |
| 2011 Q1 | 1.33 Billion CNY | 32.59% |
| 2011 Q2 | 1.47 Billion CNY | 10.78% |
| 2011 Q3 | 1.6 Billion CNY | 8.67% |
| 2010 FY | 1 Billion CNY | 0.13% |
| 2010 Q4 | 1 Billion CNY | -16.26% |
| 2010 Q3 | 1.2 Billion CNY | -5.53% |
| 2010 Q2 | 1.27 Billion CNY | 8.6% |
| 2010 Q1 | 1.17 Billion CNY | 16.54% |
| 2009 Q4 | 1 Billion CNY | 10.48% |
| 2009 FY | 1 Billion CNY | 115.18% |
| 2009 Q3 | 908.9 Million CNY | 35.25% |
| 2009 Q2 | 672.01 Million CNY | -7.71% |
| 2009 Q1 | 728.18 Million CNY | 56.04% |
| 2008 Q1 | 507.08 Million CNY | 52.68% |
| 2008 Q2 | 546.22 Million CNY | 7.72% |
| 2008 Q3 | 373.56 Million CNY | -31.61% |
| 2008 FY | 466.66 Million CNY | 40.51% |
| 2008 Q4 | 466.66 Million CNY | 24.92% |
| 2007 FY | 332.11 Million CNY | -15.86% |
| 2007 Q1 | 366.15 Million CNY | -7.23% |
| 2007 Q2 | 398.74 Million CNY | 8.9% |
| 2007 Q3 | 350.66 Million CNY | -12.06% |
| 2007 Q4 | 332.11 Million CNY | -5.29% |
| 2006 Q3 | 159.52 Million CNY | -13.3% |
| 2006 Q1 | 209.8 Million CNY | 1998.0% |
| 2006 FY | 394.7 Million CNY | 3847.06% |
| 2006 Q2 | 184 Million CNY | -12.3% |
| 2006 Q4 | 394.7 Million CNY | 147.43% |
| 2005 FY | 10 Million CNY | -20.0% |
| 2005 Q4 | 10 Million CNY | 0.0% |
| 2005 Q3 | 10 Million CNY | 0.0% |
| 2005 Q2 | 10 Million CNY | -20.0% |
| 2005 Q1 | 12.5 Million CNY | 0.0% |
| 2004 Q4 | 12.5 Million CNY | -84.85% |
| 2004 Q2 | 87.5 Million CNY | -49.13% |
| 2004 FY | 12.5 Million CNY | -93.5% |
| 2004 Q1 | 172 Million CNY | -10.58% |
| 2004 Q3 | 82.5 Million CNY | -5.71% |
| 2003 Q4 | 192.35 Million CNY | -13.25% |
| 2003 Q2 | 259.18 Million CNY | 35.69% |
| 2003 FY | 192.35 Million CNY | 11.73% |
| 2003 Q1 | 191.01 Million CNY | 10.95% |
| 2003 Q3 | 221.72 Million CNY | -14.45% |
| 2002 Q4 | 172.15 Million CNY | -24.1% |
| 2002 Q1 | 248.31 Million CNY | 3.33% |
| 2002 Q2 | 219.11 Million CNY | -11.76% |
| 2002 Q3 | 226.81 Million CNY | 3.51% |
| 2002 FY | 172.15 Million CNY | -28.36% |
| 2001 FY | 240.31 Million CNY | 356.61% |
| 2001 Q4 | 240.31 Million CNY | 0.0% |
| 2001 Q2 | 258.81 Million CNY | 0.0% |
| 2000 Q4 | 52.62 Million CNY | 0.0% |
| 2000 Q2 | 67.5 Million CNY | 0.0% |
| 2000 FY | 52.62 Million CNY | 8.98% |
| 1999 FY | 48.29 Million CNY | -30.58% |
| 1999 Q2 | 58.14 Million CNY | 0.0% |
| 1999 Q4 | 48.29 Million CNY | 0.0% |
| 1998 Q4 | 69.56 Million CNY | 0.0% |
| 1998 Q2 | 104.56 Million CNY | 0.0% |
| 1998 FY | 69.56 Million CNY | -27.03% |
| 1997 Q2 | - CNY | 0.0% |
| 1997 FY | 95.32 Million CNY | 96.95% |
| 1997 Q4 | 95.32 Million CNY | 0.0% |
| 1996 Q4 | 48.4 Million CNY | 0.0% |
| 1996 FY | 48.4 Million CNY | 206.34% |
| 1996 Q2 | - CNY | 0.0% |
| 1995 FY | 15.8 Million CNY | -58.17% |
| 1995 Q4 | 15.8 Million CNY | 0.0% |
| 1995 Q2 | - CNY | 0.0% |
| 1994 FY | 37.76 Million CNY | -25.34% |
| 1994 Q2 | - CNY | 0.0% |
| 1994 Q4 | 37.76 Million CNY | 0.0% |
| 1993 FY | 50.58 Million CNY | -31.92% |
| 1992 FY | 74.29 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Shenzhen Glory Medical Co.,Ltd. | 290.6 Million CNY | -4632.309% |
| Realcan Pharmaceutical Group Co., Ltd. | 6.82 Billion CNY | -101.519% |